Literature DB >> 31910105

Risk Stratification of Pediatric Patients with Differentiated Thyroid Cancer: Is Total Thyroidectomy Necessary for Patients at Any Risk?

Kiminori Sugino1, Mitsuji Nagahama1, Wataru Kitagawa1, Keiko Ohkuwa1, Takashi Uruno1, Kenichi Matsuzu1, Akifumi Suzuki1, Chisato Tomoda1, Kiyomi Y Hames1, Junko Akaishi1, Chie Masaki1, Koichi Ito1.   

Abstract

Background: In the recent American Thyroid Association (ATA) guidelines for adult differentiated thyroid carcinoma (DTC) patients, risk stratification is clearly defined and lobectomy is acceptable for low-risk DTC. However, risk stratification for children with DTC in the ATA pediatric guidelines is rather unclear, and total thyroidectomy is recommended for all patients with any risk. The aim of this study was to attempt risk stratification based on our experience and to consider the appropriate extent of thyroidectomy, especially for low-risk DTC in the pediatric population. Patients and
Methods: The subjects were 153 patients with DTC ≤18 years old, including 58 patients ≤15 years old and 136 female patients, who underwent initial curative surgery in our hospital between 1979 and 2014. Underlying pathology was papillary thyroid carcinoma in 130 patients and follicular thyroid carcinoma in 23. Risk factors related to disease-free survival (DFS) were analyzed and risk stratification was performed.
Results: No patient died of the disease and 34 patients (22.2%) developed recurrences. At initial surgery, 30 patients (19.6%) had lymph node metastases diagnosed before initial surgery (cN1) and 9 (5.9%) had gross extrathyroidal extension (ETE). Significant factors related to DFS on multivariate analysis were cN1, ETE, and number of metastatic lymph nodes (NMLNs) ≥10, including microscopic MLNs. According to these factors, subjects were divided into three categories: low risk (no risk factors, n = 89); intermediate risk (1 risk factor, n = 37); and high risk (≥2 risk factors, n = 27). Ten-year DFS rates in the low-, intermediate-, and high-risk groups were 96%, 83%, and 48%, respectively. Only 12% of low-risk patients underwent total thyroidectomy. Because NMLNs become obvious only after surgery, another analysis after excluding "NMLNs" as a factor showed that cN and ETE were significant factors related to poor DFS. According to these two factors, risk stratification was attempted in the same manner. Ten-year DFS rates in the low- (no risk factor, n = 117), intermediate- (one risk factor, n = 29), and high-risk (two risk factors, n = 7) groups were 92%, 59%, and 43%, respectively. Only 12% of low-risk patients underwent total thyroidectomy. Conclusions: For low-risk pediatric patients, lobectomy may be sufficient as the initial surgical procedure.

Entities:  

Keywords:  childhood; differentiated thyroid cancer; extent of thyroidectomy; risk stratification

Mesh:

Year:  2020        PMID: 31910105     DOI: 10.1089/thy.2019.0231

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  10 in total

1.  Predictors of Bilateral Disease in Pediatric Differentiated Thyroid Cancer.

Authors:  Christine E Cherella; Danielle M Richman; Enju Liu; Mary C Frates; Biren P Modi; Benjamin Zendejas; Jessica R Smith; Justine A Barletta; Monica L Hollowell; Ari J Wassner
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 5.958

Review 2.  Epidemiology and treatment of head and neck malignancies in the AYA generation.

Authors:  Takahiro Asakage
Journal:  Int J Clin Oncol       Date:  2022-01-14       Impact factor: 3.402

3.  Relationship Between Thyroid Autoantibodies and Recurrence of Papillary Thyroid Carcinoma in Children and Adolescents.

Authors:  Dongmei Huang; Jingtai Zhi; Jinming Zhang; Xuan Qin; Jingzhu Zhao; Xiangqian Zheng; Ming Gao
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

4.  SOX12 Promotes Thyroid Cancer Cell Proliferation and Invasion by Regulating the Expression of POU2F1 and POU3F1.

Authors:  Zhenxi Su; Wenqing Bao; Guanghua Yang; Jianping Liu; Bin Zhao
Journal:  Yonsei Med J       Date:  2022-06       Impact factor: 3.052

5.  Trans-oral endoscopic thyroidectomy vestibular approach (TOETVA) for the pediatric population: a multicenter, large case series.

Authors:  Oded Cohen; Ralph P Tufano; Angkoon Anuwong; Jonathon O Russell; Niddal Assadi; Gianlorenzo Dionigi; Hoon Yub Kim; Antonio Bertelli; Avi Khafif
Journal:  Surg Endosc       Date:  2021-05-24       Impact factor: 4.584

6.  Oncogene-specific inhibition in the treatment of advanced pediatric thyroid cancer.

Authors:  Aime T Franco; Julio C Ricarte-Filho; Theodore W Laetsch; Andrew J Bauer
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 19.456

Review 7.  A Search for Causes of Rising Incidence of Differentiated Thyroid Cancer in Children and Adolescents after Chernobyl and Fukushima: Comparison of the Clinical Features and Their Relevance for Treatment and Prognosis.

Authors:  Valentina Drozd; Vladimir Saenko; Daniel I Branovan; Kate Brown; Shunichi Yamashita; Christoph Reiners
Journal:  Int J Environ Res Public Health       Date:  2021-03-26       Impact factor: 3.390

8.  Pan-genomic characterization of high-risk pediatric papillary thyroid carcinoma.

Authors:  Adam Stenman; Samuel Backman; Klara Johansson; Johan O Paulsson; Peter Stålberg; Jan Zedenius; C Christofer Juhlin
Journal:  Endocr Relat Cancer       Date:  2021-04-29       Impact factor: 5.678

9.  Predictive Factors for Recurrence of Papillary Thyroid Carcinoma in Children and Adolescents.

Authors:  Yan Gui; Dongmei Huang; Yun Hou; Xudong Wei; Jinming Zhang; Junyi Wang
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

10.  Risk Factors and Prediction Model for Lateral Lymph Node Metastasis of Papillary Thyroid Carcinoma in Children and Adolescents.

Authors:  Weili Liang; Lei Sheng; Liguang Zhou; Changyuan Ding; Zhongyang Yao; Chao Gao; Qingdong Zeng; Bo Chen
Journal:  Cancer Manag Res       Date:  2021-02-16       Impact factor: 3.989

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.